Loading insider details...
Beta
Latest Form 4 (Jul 29, 2026): Conversion of 30,000 FRNM shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 29, 2026 | Freenome, Inc. (FRNM) | Conversion | 30,000 | n/a |
| Dec 11, 2024 | Lyra Therapeutics, Inc. (LYRA) | Grant/Award | 128,333 | n/a |
| Mar 20, 2024 | Lyra Therapeutics, Inc. (LYRA) | Grant/Award | 275,000 | n/a |
| Nov 13, 2023 | Lyra Therapeutics, Inc. (LYRA) | Purchase | 25,000 | $74.1K |
| Feb 2, 2023 | Lyra Therapeutics, Inc. (LYRA) | Grant/Award | 200,000 | n/a |
| Jun 21, 2022 | Lyra Therapeutics, Inc. (LYRA) | Grant/Award | 953,002 | n/a |
| Apr 13, 2022 | Lyra Therapeutics, Inc. (LYRA) | Purchase | 236,966 | $1000.0K |
| Feb 18, 2022 | Lyra Therapeutics, Inc. (LYRA) | Grant/Award | 520,000 | n/a |